Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 2,694 KNSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,694 | n/a |
| Apr 8, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,694 | n/a |
| Apr 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 5,187 | n/a |
| Mar 11, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,036 | $46.6K |
| Feb 11, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 8,374 | $108.6K |
| Jan 9, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 12,000 | $502.7K |
| Dec 10, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 16,164 | $179.4K |
| Nov 14, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 19,900 | $615.5K |
| Oct 30, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 100 | $3.1K |
| Sep 3, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 1,592 | n/a |